Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription Articles published in Neuroscience Retrieve available abstracts of 102 articles: HTML format

Single Articles

August 2026
1. BENTALL LM, Parr-Brownlie LC
   VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.
   Neuroscience. 2026 Aug 31:S0306-4522(26)00593.
   PubMed     Abstract available
   
   
   
2. LEEDOM M, Espinoza AI, Mancini M, Lench DH, et al
   Midfrontal oscillatory alterations during gait imagination and observation in Parkinson's disease with freezing of gait.
   Neuroscience. 2026;615:134-143.
   PubMed     Abstract available
   
   
   July 2026
3. SHARMA K, Chib S, Singh TG, Singh R, et al
   Pharmacological potential of wogonin in rotenone induced mice model of Parkinson's disease via targeting GSK-3beta.
   Neuroscience. 2026 Jul 27:S0306-4522(26)00501.
   PubMed     Abstract available
   
   
   
4. LIN H, Dai W, Mao H, Kuang Y, et al
   Neural compensation preserves white matter integrity in early Parkinson's disease but not atypical Parkinsonism: a diffusion tensor imaging study.
   Neuroscience. 2026 Jul 20:S0306-4522(26)00477.
   PubMed     Abstract available
   
   
   
5. KALVALA S, Abushik P, Rezaie M, Dougalis A, et al
   Air-Liquid interface midbrain organoids model the pathological features of Parkinson's disease.
   Neuroscience. 2026 Jul 17:S0306-4522(26)00472.
   PubMed     Abstract available
   
   
   
6. LIU T, Ren Y, Lin J, Wei J, et al
   ACE2 deficiency alters brain RAS signaling to induce pro-inflammatory microglial remodeling and Worsen Parkinson's disease pathology.
   Neuroscience. 2026;611:277-297.
   PubMed     Abstract available
   
   
   June 2026
7. HUANG C, Tan C, Shen Q, Liu Q, et al
   Disrupted brain functional network topology and potential network reorganization in early-stage Parkinson's disease with probable REM sleep behavior disorder.
   Neuroscience. 2026 Jun 25:S0306-4522(26)00423.
   PubMed     Abstract available
   
   
   
8. ROHR-FUKUMA M, Stieglitz LH, Bujan B, Imbach LL, et al
   Explorative investigation on effects of multi-day neurofeedback with implanted electrodes in patients with Parkinson's disease.
   Neuroscience. 2026 Jun 24:S0306-4522(26)00391.
   PubMed     Abstract available
   
   
   
9. YANG H, Zhang K, Niu M, Qian Q, et al
   The protective effect of biochanin A on LPS/TNF-alpha-induced PD models is exerted by regulating ferroptosis through the Sirt1/Nrf2/GPX4 signaling pathway.
   Neuroscience. 2026;605:91-107.
   PubMed     Abstract available
   
   
   
10. SHALABI MG, Al-Kuraishy HM, Shokr MM, Batiha GE, et al
    Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson's disease: from pathogenesis to therapeutic potential.
    Neuroscience. 2026;610:297-310.
    PubMed     Abstract available
    
    
    
11. TANIGUCHI S, Dijkstra BW, D'cruz N, Nieuwboer A, et al
    Task-dependent changes in effective connectivity from limbic to cognitive networks during motor imagery of freezing of gait in Parkinson's disease.
    Neuroscience. 2026 Jun 15:S0306-4522(26)00390.
    PubMed     Abstract available
    
    
    
12. LIU T, Cao S, Liang H, Wei J, et al
    Exploratory multi?omics analysis for candidate biomarker identification in Parkinson's disease.
    Neuroscience. 2026 Jun 1:S0306-4522(26)00358.
    PubMed     Abstract available
    
    
    May 2026
13. WANG H, An S, Liu H, Xu H, et al
    Propagation effects of abnormal beta oscillations on sleep rhythms in Parkinson's disease: A computational study.
    Neuroscience. 2026 May 18:S0306-4522(26)00315.
    PubMed     Abstract available
    
    
    April 2026
14. LI B, Wu S, Wang G, Guo J, et al
    Functional cortical network alterations in Parkinson's disease with wearing-off revealed by resting-state fNIRS and graph theory.
    Neuroscience. 2026;606:14-23.
    PubMed     Abstract available
    
    
    
15. ASADPOORDEZAKI Z, Prehn JHM
    Neuronal vulnerability in Parkinson's disease: insights from murine alpha-synuclein pathology models.
    Neuroscience. 2026 Apr 17:S0306-4522(26)00261.
    PubMed     Abstract available
    
    
    
16. BIZET B, Trinchi M, Nardello F, Bombieri F, et al
    Quantitative ultrasound radiofrequency analysis for monitoring Parkinson's disease.
    Neuroscience. 2026 Apr 7:S0306-4522(26)00254.
    PubMed     Abstract available
    
    
    March 2026
17. KITCHIGINA VF, Shubina L
    Cannabinoids and cognition in Parkinson's disease: Insights from animal models and emerging clinical evidence.
    Neuroscience. 2026;603:37-49.
    PubMed     Abstract available
    
    
    February 2026
18. HU ZX, He YZ, Huang X, Wen Z, et al
    Integrative analysis of spontaneous brain activity in Parkinson's disease: associations with gene expression, cell types, and receptor density.
    Neuroscience. 2026 Feb 25:S0306-4522(26)00146.
    PubMed     Abstract available
    
    
    
19. REN B, Yan H, Han C, Sun S, et al
    How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review.
    Neuroscience. 2026 Feb 21:S0306-4522(26)00139.
    PubMed     Abstract available
    
    
    
20. PANDA SP, Saraswat N, Singh V
    Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
    Neuroscience. 2026 Feb 21:S0306-4522(26)00138.
    PubMed     Abstract available
    
    
    
21. SHI X, Liang K, Ma J, Fu C, et al
    The retinal nerve fiber layer mean thickness in patients with early Parkinson's disease reflects striatal dopamine function.
    Neuroscience. 2026;599:94-102.
    PubMed     Abstract available
    
    
    
22. ZHANG Y, Liu T, Li X, Liu S, et al
    Neuroprotective effects of idebenone in a zebrafish model of Parkinson's disease via regulating autophagy, mitigating apoptosis and oxidative stress.
    Neuroscience. 2026 Feb 13:S0306-4522(26)00111.
    PubMed     Abstract available
    
    
    
23. LI M, Guo R, Liu M, Xu L, et al
    Glutamate chemical exchange saturation transfer imaging reveals cerebellar glutamatergic alterations in Parkinson's disease subtypes.
    Neuroscience. 2026 Feb 11:S0306-4522(26)00112.
    PubMed     Abstract available
    
    
    January 2026
24. CALZETTI S, Negrotti A
    Dopamine antagonists-induced parkinsonism: the crucial role of individual susceptibility associated to positive family history.
    Neuroscience. 2026 Jan 31:S0306-4522(26)00079.
    PubMed    
    
    
    
25. MACEDO TO, Cabral LM, Miranda NC, Scorza FA, et al
    Omega-3 supplementation prevents functional and neural respiratory damage present in an animal model of Parkinson's disease.
    Neuroscience. 2026 Jan 14:S0306-4522(26)00040.
    PubMed     Abstract available
    
    
    December 2025
26. ZHAO L, Han K, Sun L
    Investigations on the effects of SH2B2 on Parkinson's disease based on its in vivo and in vitro neurotoxic model.
    Neuroscience. 2025 Dec 31:S0306-4522(25)01236.
    PubMed     Abstract available
    
    
    
27. LI Y, Bo S, Qu JF, Ruan X, et al
    Alterations of functional connectivity between hyperdirect pathway regions and outside regions in Parkinson's disease patients with freezing of gait.
    Neuroscience. 2025 Dec 23:S0306-4522(25)01225.
    PubMed     Abstract available
    
    
    
28. SANCHEZ-MONCADA I, Neri-Nani G, Jefte AE, Merchant H, et al
    Preferred tempo influence on learning transfer from perceptual to stepping timing in Parkinson's disease.
    Neuroscience. 2025 Dec 17:S0306-4522(25)01206.
    PubMed     Abstract available
    
    
    
29. MOHAMED YA, Ahmed Nadeem AA, Ismail LM, Ghallab YK, et al
    Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson's disease.
    Neuroscience. 2025 Dec 9:S0306-4522(25)01160.
    PubMed     Abstract available
    
    
    
30. SARKAR S, Podder S
    Profiling the Braak progression in Parkinson's disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature.
    Neuroscience. 2025;593:41-55.
    PubMed     Abstract available
    
    
    November 2025
31. SI Q, Shi J, Cao X, Gan C, et al
    Alterations in cortical sulcal morphology in Parkinson's disease patients with impulse control disorders.
    Neuroscience. 2025;591:149-156.
    PubMed     Abstract available
    
    
    October 2025
32. YU Q, Hu J, Cui J, Shi Q, et al
    Dynamic network reconfiguration in Parkinson's disease: associations with cognition and transcriptional signatures.
    Neuroscience. 2025 Oct 14:S0306-4522(25)01014.
    PubMed     Abstract available
    
    
    
33. LAVRINOVA AO, Litusova EM, Gagarina PA, Dmitriev AA, et al
    Decreased DNA methyltransferase 1 level in blood cells in Parkinson's disease.
    Neuroscience. 2025 Oct 14:S0306-4522(25)01017.
    PubMed     Abstract available
    
    
    
34. KUMARI S, Kumaran S, Rajan R, Arora S, et al
    Neurobiochemical alterations in patients with idiopathic Parkinson's disease in sensorimotor cortex using 1H-MRS.
    Neuroscience. 2025 Oct 12:S0306-4522(25)01006.
    PubMed     Abstract available
    
    
    
35. CHAHRA C, Sawssen M, Anis H, Salma N, et al
    Randomized, placebo-controlled pilot study of Origanum majorana tea on oxidant/antioxidant stress biomarkers in Parkinson's idiopathic disease: a randomized controlled pilot Tunisian study.
    Neuroscience. 2025 Oct 4:S0306-4522(25)00977.
    PubMed     Abstract available
    
    
    September 2025
36. MADHUSUDHAN K, Padmanaban A, Parvathi VD
    Early detection of Parkinson's disease via aptamer-CRISPR platform.
    Neuroscience. 2025 Sep 20:S0306-4522(25)00951.
    PubMed     Abstract available
    
    
    
37. BAO W, Ge Y, Huang J, Li Y, et al
    DJ-1/PARK7 in Parkinson's disease: mechanisms of pathogenesis and therapeutic potential.
    Neuroscience. 2025 Sep 19:S0306-4522(25)00949.
    PubMed     Abstract available
    
    
    
38. SINGH H, Kumari S, Taliyan R
    Epigenetic mechanisms linking environmental exposure to Parkinson's disease: A comprehensive review.
    Neuroscience. 2025;585:367-380.
    PubMed     Abstract available
    
    
    
39. ZHIDAN L, Xianjie L, Shulin S, Qiang J, et al
    TREM2 mediates parkinsonism-like neurodegeneration in carbon disulfide-induced neurotoxicity.
    Neuroscience. 2025;585:50-59.
    PubMed     Abstract available
    
    
    August 2025
40. ATANASOVSKI D, Bergquist F, Eriksson E, Carlsson T, et al
    The dopamine stabilizer (-)-OSU6162 attenuates levodopa-induced dyskinesia in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Neuroscience. 2025 Aug 23:S0306-4522(25)00889.
    PubMed     Abstract available
    
    
    
41. DA SILVA CHAAR NETA R, da Silva Batista C, Machado Palmerim EM, Costa Dias HM, et al
    The impact of social isolation due to the COVID-19 pandemic on functional performance, fall risk, and gait in individuals with Parkinson's Disease: a systematic review.
    Neuroscience. 2025;584:113-126.
    PubMed     Abstract available
    
    
    
42. GWEDELA MNV, Gadama Y, Phiri TE
    Parkinson's disease in Malawi: A cross-sectional Study of clinical profiles and risk factors.
    Neuroscience. 2025;584:88-92.
    PubMed     Abstract available
    
    
    July 2025
43. WANG B, Zhao Z, Guo RN, Wu X, et al
    Enhanced focality and intensity in deep brain targeting: In silico study on multi-channel temporal interference stimulation for Parkinson's disease.
    Neuroscience. 2025;582:72-81.
    PubMed     Abstract available
    
    
    
44. SONG J, Wang X, Dong L, Hui S, et al
    Identification of differentially co-expressed genes with lipid metabolism in Parkinson's disease by bioinformatics analysis.
    Neuroscience. 2025;581:58-71.
    PubMed     Abstract available
    
    
    
45. YADAV S, Raj RG
    Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons.
    Neuroscience. 2025;581:1-15.
    PubMed     Abstract available
    
    
    June 2025
46. WANG Z, Liu Y, Li C, Qin K, et al
    Music-based intervention as a new therapeutic treatment for executive dysfunction in Parkinson's disease.
    Neuroscience. 2025;580:306-314.
    PubMed     Abstract available
    
    
    
47. HU L, Han J, Ma R, Cheng J, et al
    Cathodal high-definition transcranial direct current stimulation improves sleep and motor symptoms in Parkinson's disease with possible rapid eye movement sleep behaviors disorder: A pilot open-label study.
    Neuroscience. 2025 Jun 27:S0306-4522(25)00738.
    PubMed     Abstract available
    
    
    
48. ZABALA-GOMEZ O, Ibarretxe-Bilbao N, Tijero B, Gabilondo I, et al
    Fatigue brain network functional connectivity in Parkinson's disease.
    Neuroscience. 2025 Jun 3:S0306-4522(25)00674.
    PubMed     Abstract available
    
    
    May 2025
49. CHEN D, Jiang Y, Ge F, Liu X, et al
    High-frequency repetitive transcranial magnetic stimulation upregulates BDNF expression and promotes synaptogenesis in mouse models of Parkinson's disease.
    Neuroscience. 2025 May 30:S0306-4522(25)00671.
    PubMed     Abstract available
    
    
    
50. KUANG Z, Huang X, Wang M, Bu S, et al
    Thalamic free water elevation and its association with glymphatic dysfunction in Parkinson's disease: A cross-sectional and longitudinal study.
    Neuroscience. 2025 May 27:S0306-4522(25)00667.
    PubMed     Abstract available
    
    
    
51. QIN K, Liu Y, Xue L, Li H, et al
    Resting-state fMRI study on male patients with Parkinson's disease and with sexual dysfunction.
    Neuroscience. 2025 May 19:S0306-4522(25)00392.
    PubMed     Abstract available
    
    
    
52. GLASBAUER ND, Sookoian S, Pirola CJ
    Identifying molecular pathways of olfactory dysfunction in Parkinson's disease through a systems biology framework.
    Neuroscience. 2025 May 19:S0306-4522(25)00393.
    PubMed     Abstract available
    
    
    
53. RUST C, van den Heuvel LL, Bardien S, Carr J, et al
    Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson's disease.
    Neuroscience. 2025;576:149-154.
    PubMed     Abstract available
    
    
    April 2025
54. GOLDBERG NRS, Haack AK, Meshul CK
    Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452].
    Neuroscience. 2025 Apr 17:S0306-4522(25)00224.
    PubMed    
    
    
    
55. PARACKA L, Heldmann M, Lange F, Saryyeva A, et al
    Subthalamic nucleus dynamics during executive functioning: Insights from local field potentials in Parkinson's disease.
    Neuroscience. 2025 Apr 8:S0306-4522(25)00283.
    PubMed     Abstract available
    
    
    
56. MEHREEN M, Ali M, Tariq H, Noor A, et al
    Chenodeoxycholic Acid-Mediated neuroprotection via alpha-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson's disease.
    Neuroscience. 2025;573:442-450.
    PubMed     Abstract available
    
    
    March 2025
57. LAU F, Binacchi R, Brugnara S, Cumplido-Mayoral A, et al
    Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease.
    Neuroscience. 2025 Mar 26:S0306-4522(25)00244.
    PubMed     Abstract available
    
    
    
58. SHARMA V, Unjum Saqib BZ, Aran KR
    Leptin as a potential neuroprotective target in Parkinson's Disease: Exploring its role in Neuroinflammation, oxidative Stress, and dopaminergic neurodegeneration.
    Neuroscience. 2025;572:134-144.
    PubMed     Abstract available
    
    
    
59. GOLDBERG NRS, Haack AK, Meshul CK
    Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452].
    Neuroscience. 2025;571:31.
    PubMed    
    
    
    February 2025
60. ZHANG T, Jin Z, Chen K, Pei G, et al
    Characteristics of multimodal physiological signal differences in symptom fluctuations in Parkinson's disease.
    Neuroscience. 2025;569:322-330.
    PubMed     Abstract available
    
    
    January 2025
61. ZUO Y, Ding X, Liu Z, Xie Y, et al
    Diverse pathways for the treatment of Parkinson's disease: Integration and development of traditional and emerging therapies.
    Neuroscience. 2025 Jan 26:S0306-4522(25)00057.
    PubMed     Abstract available
    
    
    
62. ZHENG D, Chen J
    MicroRNAs in Parkinson's disease: From pathogenesis to diagnostics and therapeutic strategies.
    Neuroscience. 2025;568:298-313.
    PubMed     Abstract available
    
    
    
63. BERGAMINO M, Fuentes A, Sandoval IM, Marmion DJ, et al
    Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson's disease.
    Neuroscience. 2025;568:2-11.
    PubMed     Abstract available
    
    
    
64. LIU M, Wang J, Wang R, Sun F, et al
    MRI evaluation of neuroprotective effects of Astragaloside ? on rotenone-induced late-stage Parkinson's disease mice.
    Neuroscience. 2025 Jan 4:S0306-4522(24)00753.
    PubMed     Abstract available
    
    
    December 2024
65. YIN N, Li P, Li X, Li X, et al
    Increased alpha-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson's disease.
    Neuroscience. 2024 Dec 30:S0306-4522(24)00763.
    PubMed     Abstract available
    
    
    
66. DWIVEDI A, Kumar A, Faruq M, Singh VK, et al
    Co-occurrence of Parkinson's disease and Retinitis Pigmentosa: A genetic and in silico analysis.
    Neuroscience. 2024;565:519-526.
    PubMed     Abstract available
    
    
    
67. ABSALYAMOVA M, Traktirov D, Burdinskaya V, Artemova V, et al
    Molecular basis of the development of Parkinson's disease.
    Neuroscience. 2024;565:292-300.
    PubMed     Abstract available
    
    
    November 2024
68. XIAO K, Li J, Zhou L, Liu X, et al
    Retinopathy in Parkinson's disease: A potential biomarker for early diagnosis and clinical assessment.
    Neuroscience. 2024 Nov 29:S0306-4522(24)00692.
    PubMed     Abstract available
    
    
    
69. ZHAO X, Xiao P, Gui H, Xu B, et al
    Combined graph convolutional networks with a multi-connection pattern to identify tremor-dominant Parkinson's disease and Essential tremor with resting tremor.
    Neuroscience. 2024;563:239-251.
    PubMed     Abstract available
    
    
    
70. LI H, Li C, Ma W, Qin K, et al
    Eye movement disorders: A new approach to preliminary screening of Parkinson's disease.
    Neuroscience. 2024;563:202-211.
    PubMed     Abstract available
    
    
    
71. MI X, Li M, Zhang Y, Qu L, et al
    Intracerebroventricular injection of alpha-synuclein preformed fibrils do not induce motor and olfactory impairment in C57BL/6 mice.
    Neuroscience. 2024;559:293-301.
    PubMed     Abstract available
    
    
    
72. YUAN J, Dong X, Zhou S, Nao J, et al
    Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review.
    Neuroscience. 2024 Nov 1:S0306-4522(24)00565.
    PubMed     Abstract available
    
    
    October 2024
73. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
    Corrigendum to "Assessing the location, relative expression and subclass of dopamine receptors in the cerebellum of hemi-parkinsonian rats" [Neuroscience 521 (2023) 1-19].
    Neuroscience. 2024 Oct 25:S0306-4522(24)00561.
    PubMed    
    
    
    
74. LIANG X, Wen Y, Feng C, Xu L, et al
    Neuroglobin protects dopaminergic neurons in a Parkinson's cell model by interacting with mitochondrial complex NDUFA10.
    Neuroscience. 2024;562:43-53.
    PubMed     Abstract available
    
    
    
75. LEE HM, Lee DH, Lee HG, Kwon S, et al
    Functional neural substrates of Parkinson's disease and potential underpinnings of acute responses to acupuncture stimulation.
    Neuroscience. 2024 Oct 22:S0306-4522(24)00534.
    PubMed     Abstract available
    
    
    September 2024
76. MAO Z, Zhang Y, Liang Y, Xia C, et al
    Liver?X?receptor alpha contribution to neuroinflammation and glial cells activation induced by MPTP: Implications for Parkinson's disease.
    Neuroscience. 2024 Sep 19:S0306-4522(24)00485.
    PubMed     Abstract available
    
    
    
77. KUMAR BEURA S, Yadav P, Ramachandra Panigrahi A, Sahoo G, et al
    Impact of 6-Hydroxydopamine on Agonist-Induced human platelet functional Parameters: An explanation for platelet impairment in Parkinson's disease.
    Neuroscience. 2024 Sep 9:S0306-4522(24)00466.
    PubMed     Abstract available
    
    
    August 2024
78. CIERI F, Giriprakash PP, Nandy R, Zhuang X, et al
    Functional connectivity differences of the olfactory network in Parkinson's Disease, mild cognitive impairment and cognitively normal individuals: A resting-state fMRI study.
    Neuroscience. 2024 Aug 21:S0306-4522(24)00428.
    PubMed     Abstract available
    
    
    
79. MEILAN S, Song W, Oumei C, Kai X, et al
    Constipation is associated with emotional and cognitive impairment in patients with Parkinson's disease: a clinical and brain functional study.
    Neuroscience. 2024 Aug 19:S0306-4522(24)00413.
    PubMed     Abstract available
    
    
    
80. LUO H, Yu X, Li P, Hu J, et al
    Different neurotoxicity and seeding activity between alpha-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy.
    Neuroscience. 2024;557:1-11.
    PubMed     Abstract available
    
    
    July 2024
81. DUNCAN SJ, Marques K, Fawkes J, Smith LJ, et al
    Galvanic Vestibular Stimulation Modulates EEG Markers of Voluntary Movement in Parkinson's Disease.
    Neuroscience. 2024 Jul 27:S0306-4522(24)00368.
    PubMed     Abstract available
    
    
    
82. ANANDHAN A, Janakiraman U, Manivasagam T
    RETRACTED: "Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease" [Neurosci. 218 (2012) 25
    Neuroscience. 2024 Jul 26:S0306-4522(24)00365.
    PubMed    
    
    
    
83. LIU T, Li J, Sun L, Zhu C, et al
    The role of ACE2 in RAS axis on microglia activation in Parkinson's disease.
    Neuroscience. 2024 Jul 8:S0306-4522(24)00281.
    PubMed     Abstract available
    
    
    June 2024
84. HUANG M, Yu H, Lyu X, Pu W, et al
    Region-specific cerebral metabolic alterations in Parkinson's disease patients with/without mild cognitive impairment.
    Neuroscience. 2024 Jun 5:S0306-4522(24)00241.
    PubMed     Abstract available
    
    
    
85. KUMARI S, Rana B, Senthil Kumaran S, Chaudhary S, et al
    Gray matter atrophy in a 6-OHDA-induced model of Parkinson's disease.
    Neuroscience. 2024 Jun 4:S0306-4522(24)00229.
    PubMed     Abstract available
    
    
    May 2024
86. DA SILVA OLIVEIRA B, Cristina de Brito Toscano E, Katharina Sabino Abreua L, de Barros Fernandes H, et al
    Nigrostriatal inflammation is associated with nonmotor symptoms in an experimental model of prodromal Parkinson's disease.
    Neuroscience. 2024 May 13:S0306-4522(24)00205.
    PubMed     Abstract available
    
    
    
87. HUANG W, Zhang T, Li X, Gong L, et al
    Intranasal administration of umbilical cord mesenchymal stem cell exosomes alleviates Parkinson's disease.
    Neuroscience. 2024 May 3:S0306-4522(24)00169.
    PubMed     Abstract available
    
    
    April 2024
88. FASCIANI I, Petragnano F, Bono F, Aloisi G, et al
    In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons.
    Neuroscience. 2024;544:104-116.
    PubMed     Abstract available
    
    
    March 2024
89. SALLY SAMSON J, Ramesh A, Deepa Parvathi V
    Development of midbrain dopaminergic neurons and the advantage of using hiPSCs as a model system to study Parkinson's disease.
    Neuroscience. 2024 Mar 22:S0306-4522(24)00138.
    PubMed     Abstract available
    
    
    
90. DENG HW, Li BR, Zhou SD, Luo C, et al
    Revealing Novel Genes Related to Parkinson's Disease Pathogenesis and Establishing an associated Model.
    Neuroscience. 2024;544:64-74.
    PubMed     Abstract available
    
    
    
91. ZHU D, Zhang S, Wang X, Xiao C, et al
    Secretory Clusterin Inhibits Dopamine Neuron Apoptosis in MPTP Mice by Preserving Autophagy Activity.
    Neuroscience. 2024;540:38-47.
    PubMed     Abstract available
    
    
    November 2023
92. MANSOUR HM, Mohamed AF, Khattab MM, El-Khatib AS, et al
    Heat Shock Protein 90 in Parkinson's disease: Profile of a serial killer.
    Neuroscience. 2023 Nov 29:S0306-4522(23)00532.
    PubMed     Abstract available
    
    
    October 2023
93. SUBRAMANIYAN S, Briget Kuriakose B, Mushfiq S, Marimuthu Prabhu N, et al
    Gene signals and SNPs associated with Parkinson's disease: A nutrigenomics and computational prospective insights.
    Neuroscience. 2023 Oct 17:S0306-4522(23)00457.
    PubMed     Abstract available
    
    
    
94. DZOLJIC E, Saric Matutinovic M, Stojkovic O, Velickovic J, et al
    Vitamin D serum levels and vitamin D receptor genotype in patients with Parkinson's disease.
    Neuroscience. 2023 Oct 11:S0306-4522(23)00454.
    PubMed     Abstract available
    
    
    September 2023
95. HUANG J, Yuan X, Chen L, Hu B, et al
    The biology, pathological roles of exosomes and their clinical application in Parkinson(')s disease.
    Neuroscience. 2023 Sep 7:S0306-4522(23)00409.
    PubMed     Abstract available
    
    
    July 2023
96. ZHOU L, Li Y, Wang M, Han W, et al
    Disruption of alpha-Synuclein Proteostasis in the Striatum and Midbrain of Long-term Ovariectomized Female Mice.
    Neuroscience. 2023;523:80-90.
    PubMed     Abstract available
    
    
    
97. YUAN Y, Zhang X, Wu Y, Lian P, et al
    ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage.
    Neuroscience. 2023;523:61-79.
    PubMed     Abstract available
    
    
    June 2023
98. PEDRO AMORIM NETO D, Vitor Pereira de Godoy J, Tostes K, Pelegrini Bosque B, et al
    Metabolic disturbances in the gut-brain axis of a mouse model of MPTP-induced Parkinsonism evaluated by Nuclear Magnetic Resonance.
    Neuroscience. 2023 Jun 16:S0306-4522(23)00266.
    PubMed     Abstract available
    
    
    
99. PU Z, Liu S, Guo Z, Zhang X, et al
    Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.
    Neuroscience. 2023 Jun 13:S0306-4522(23)00225.
    PubMed     Abstract available
    
    
    April 2023
100. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
     Assessing the Location, Relative Expression and Subclass of Dopamine Receptors in the Cerebellum of Hemi-Parkinsonian Rats.
     Neuroscience. 2023 Apr 26:S0306-4522(23)00143.
     PubMed     Abstract available
     
     
     March 2023
101. KANDIL EA, Abdelkader NF, El-Sayeh BM, Saleh S, et al
     Corrigendum to "Imipramine and Amitriptyline Ameliorate the Rotenone Model of Parkinson's Disease in Rats" [Neuroscience 332 (2016) 26-37].
     Neuroscience. 2023 Mar 6:S0306-4522(23)00120.
     PubMed    
     
     
     February 2023
102. LOU T, Tao B, Chen M
     Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.
     Neuroscience. 2023 Feb 2:S0306-4522(23)00055.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum